Harnessing Cellular Immunity for Vaccination against Respiratory Viruses

Severe respiratory viral infections, such as influenza, metapneumovirus (HMPV), respiratory syncytial virus (RSV), rhinovirus (RV), and coronaviruses, including severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), cause significant mortality and morbidity worldwide. These viruses have been...

Descripción completa

Detalles Bibliográficos
Autores principales: Lukacs, Nicholas W., Malinczak, Carrie-Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766447/
https://www.ncbi.nlm.nih.gov/pubmed/33371275
http://dx.doi.org/10.3390/vaccines8040783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766447/
https://www.ncbi.nlm.nih.gov/pubmed/33371275
http://dx.doi.org/10.3390/vaccines8040783

Ejemplares similares